SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RevMikeB who wrote (23153)7/14/1998 12:33:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
The street has pretty much ignored the SRGN deal and teh ONTAK approval rec. The price did dip a bit when the FDA letter was announced, but misleading info was posted by some of our naysayers, and some investors probably bought that story (at least for a short time).

Now however, LGND is focusing more and more on products and profits, so the street may give the final approval a positive response, especially since the deal should generate profits as early as next year (or possible by 4Q of this year)..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News